Spruce Biosciences, Inc. (SPRB) Tops Q2 EPS by 7c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
• Alliance Laundry Holdings Inc. (ALH) Tops Q1 EPS by 6c
• Tapestry (TPR) Tops Q4 EPS by 7c; offers guidance